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Neglected Diseases
R
ecent experience with SARS (severe acute respiratory 
syndrome) [1] and avian flu shows that the 
public and political response to threats from new 
anthropozoonoses can be near-hysteria. This can readily make 
us forget more classical animal-borne diseases, such as plague 
(Box 1). 
Three recent international meetings on plague (Box 2) 
concluded that: (1) it should be re-emphasised that the 
plague bacillus (Yersinia pestis) still causes several thousand 
human cases per year [2,3] (Figure 1); (2) locally perceived 
risks far outstrip the objective risk based purely on the 
number of cases [2]; (3) climate change might increase the 
risk of plague outbreaks where plague is currently endemic 
and new plague areas might arise [2,4]; (4) remarkably little 
is known about the dynamics of plague in its natural reservoirs 
and hence about changing risks for humans [5]; and, 
therefore, (5) plague should be taken much more seriously by 
the international community than appears to be the case. 
The Plague Eco-Epidemiological System
The plague bacillus causes a rapidly progressing, serious 
illness that in its bubonic form is likely to be fatal (40%–70% 
mortality). Without prompt antibiotic treatment, pneumonic 
and septicaemic plague are virtually always fatal. For these 
reasons Y. pestis is considered one of the most pathogenic 
bacteria for humans. 
Yersinia pestis is transmitted by fleas, while the other two 
species of Yersinia known to be pathogenic for humans 
(Y. enterocolitica and Y. pseudotuberculosis) are transmitted 
by the faecal–oral route and cause intestinal symptoms of 
moderate intensity. Yersinia pestis is believed to be a clone 
of Y. pseudotuberculosis that emerged within the last 1,500 to 
20,000 years [6,7]. This divergence was characterised by the 
acquisition of a few genetic elements; more particularly, two 
plasmids that play a key role in flea-borne transmission [8,9]. 
The exceptional pathogenicity of Y. pestis compared to the 
enteropathogenic species may be explained by its new mode 
of transmission. Indeed, the only means for this bacterium 
to be transferred to new hosts is through septicaemia, 
which allows the bacteria present in the bloodstream to be 
efficiently taken up by the flea during its blood meal [10].
Soon after Yersin’s identification of the plague bacillus 
[11], it became clear that urban outbreaks were linked to 
transmission among commensal rats and their fleas. In this 
classic urban-plague scenario, infected rats (transported, 
for example, by ships) arrive in a new city and transmit the 
infection to local house rats and their fleas, which then serve 
as sources of human infection. Occasionally, humans develop 
a pneumonic form of plague that is then directly transmitted 
from human to human through respiratory droplets. 
The epidemiology of plague, however, is much more 
complicated than this urban-plague scenario suggests, 
involving several other—more likely—pathways of 
transmission (Box 3 and Figure 2). This complicated 
epidemiology necessitates a reconsideration of plague 
ecology. 
The Past
Plague has given rise to at least three major pandemics. 
The first (“the Justinian plague”) spread around the 
Mediterranean Sea in the 6th century AD, the second (“the 
Black Death”) started in Europe in the 14th century and 
recurred intermittently for more than 300 years, and the third 
started in China during the middle of the 19th century and 
spread throughout the world. Purportedly, each pandemic 
was caused by a different biovar of Y. pestis, respectively, 
Antiqua (still found in Africa and Central Asia), Medievalis 
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(currently limited to Central Asia), and Orientalis (almost 
worldwide in its distribution) [12,13]. 
The Black Death decimated Medieval Europe, and 
had a major impact on the continent’s socio-economic 
development, culture, art, religion, and politics [14,15]. 
Several high-profile critiques have questioned whether 
the Black Death was indeed caused by Y. pestis [16,17]. 
Proponents of both sides of the debate came together at last 
year’s Oslo and London meetings (Box 2). It was generally 
accepted that the epidemiology of Black Death plague, as 
reflected in historical records, did not always match the 
“classical” rat-flea-human plague cycle. However, the reported 
medical symptoms were very similar during each pandemic. In 
addition, the international experience of modern-day plague 
represented at the Oslo meeting made it clear that “classical” 
plague epidemiology is only one of several possibilities to 
explain the Black Death, and may not even be the most typical 
of the different plague ecology systems [18]. Discovery of Y. 
pestis genetic material in those who died from the Black Death 
and are buried in medieval graves [19] further supports the 
view that Y. pestis was the causative agent of the Black Death. 
The Present
Given this history, plague is often classified as a problem of 
the past. However, it remains a current threat in many parts 
of the world (Figure 1A), particularly in Africa, where both 
the number of cases (Figure 1B) and the number of countries 
reporting plague (Figure 1C) have increased during recent 
decades. Following the reappearance of plague during the 
1990s in several countries, plague has been categorised as a 
re-emerging disease [20,21].
Plague is endemic in a variety of wildlife rodent species 
worldwide in a wide range of natural habitats, with commensal 
rats only sometimes playing a role as “liaison” hosts, carrying 
plague between the sylvatic reservoir and people. Various 
other animal-to-human transmission pathways have been 
documented. Human plague may be contracted from (1) 
being bitten by the fleas of wildlife rodent species in rural 
settings (e.g., in the south-western United States [22,23]) 
or of commensal rodents that move freely between villages 
and the forest habitats occupied by reservoir hosts (e.g., in 
Tanzania); rodents’ movements have become more frequent 
as human activity has fragmented the forest [24]; (2) eating 
infected animals such as guinea pigs in Peru and Ecuador 
[25,26] or camels that contract the disease from rodent fleas 
in Central Asia and the Middle East [27–31]; or (3) handling 
cats infected through the consumption of plague-infected 
rodents in Africa or the United States [32–34]. Human-to-
human transmission also occurs, either directly through 
respiratory droplets or indirectly via flea bites [35–37].
doi:10.1371/journal.pmed.0050003.g001
Figure 1. The Global Distribution of Plague
(A) Map showing countries with known presence of plague in wild reservoir species (red) (after [3]). For US only the mainland below 50º N is shown. (B) 
Annual number of human plague cases over different continents, reported to WHO in the period 154–2005. (C) Cumulative number of countries that 
reported plague to WHO since 154. 
PLoS Medicine  |  www.plosmedicine.org 0011 January 2008  |  Volume 5  |  Issue 1  |  e3
Over the last 20 years, there have been 1,000 to 5,000 
human cases of plague and 100 to 200 deaths reported to the 
World Health Organization (WHO) each year [38]. However, 
because of poor diagnostic facilities and underreporting, 
the number of cases is almost certainly much higher. Over 
the years, there has been a major shift in cases from Asia 
to Africa (Figure 1B), with more than 90% of all cases 
and deaths in the last five years occurring in Madagascar, 
Tanzania, Mozambique, Malawi, Uganda, and the Democratic 
Republic of the Congo (DRC). Most are cases of bubonic 
plague contracted through contact with infected rodents and 
fleas. However, outbreaks of pneumonic plague still occur: 
the most recent large one was in October and November 
2006 in DRC, with hundreds of suspected cases [39], and 
a smaller outbreak arose just across the border in nearby 
Uganda in February 2007 ([40]). In December 2004 there 
was a pneumonic outbreak in a miners’ camp in DRC, 
probably imported by an infected human who had travelled 
from an endemic zone. One pneumonic case even arrived 
in Kisangani, a large city several hundred kilometres away 
[41,42]. So even rapid-reaction medical teams may not be 
sufficient to stop plague from spreading quickly over long 
distances before it is detected and managed. 
Africa is particularly at risk for a number of reasons. Poor 
rural communities typically live in close proximity to rodents, 
which are widely hunted and eaten in many plague-endemic 
areas. Superstitions, lack of money, and distance from health 
facilities often lead to delays in seeking health care and 
receiving treatment. The public health system in large parts 
of Africa is poorly organised and equipped, and political crisis 
and social disorganisation impede improvements. Finally, 
anthropogenic changes to the landscape and to patterns of 
human mobility are increasingly favouring contact between 
plague-reservoir and peri-domestic rodents, and between 
people from plague-endemic and previously unaffected 
regions. 
Looking to the Future
Plague cannot be eradicated, since it is widespread in 
wildlife rodent reservoirs. Hence, there is a critical need to 
understand how human risks are affected by the dynamics 
of these wildlife reservoirs. For example, the likelihood of 
a plague outbreak in North American and Central Asian 
rodents, and the resulting risk to humans, is known to be 
affected by climate [43,44]. Recent analysis of data from 
Kazakhstan [45] shows that warmer springs and wetter 
summers increase the prevalence of plague in its main host, 
the great gerbil. Such environmental conditions also seem 
to have prevailed during the emergence of the Second and 
Third Pandemics [46,47]—conditions that might become 
more common in the future [48]. 
Although the number of human cases of plague is relatively 
low, it would be a mistake to overlook its threat to humanity, 
because of the disease’s inherent communicability, rapid 
spread, rapid clinical course, and high mortality if left 
untreated. A plague outbreak may also cause widespread 
panic, as occurred in India in 1994 when a relatively small 
outbreak, with 50 deaths, was reported in the city of Surat 
[49]. This led to a nationwide collapse in tourism and trade, 
with an estimated cost of US$600 million [50]. 
Outbreaks are usually tackled with a fire-fighting 
approach. Teams move into an infected area to kill fleas with 
insecticides, treat human cases, and give chemoprophylaxis 
to exposed people. Many experts have argued that this crisis-
management approach is insufficient as the outbreak is likely 
to be on the wane by the time action is taken. Informed, 
pre-emptive decisions about plague management and 
prevention before outbreaks occur would certainly be more 
sustainable and cost-beneficial. There has been some recent 
progress, such as development of rapid diagnosis tools [51], 
some challenging of accepted dogma about the dynamics 
of sylvatic plague in the United States [52] and in Central 
Asia [53], and the identification of predictive critical rodent 
abundance thresholds for plague in Kazakhstan [54]. What 
Box 1. The Plague 
The causative bacterium (Yersinia pestis) was discovered 
by Yersin in 184 [11] (see also [63]). Case-fatality ratio varies 
from 30% to 100%, if left untreated. Plague is endemic in many 
countries in the Americas, Asia, and Africa. More than 0% of 
cases are currently being reported from Africa. 
Clinical presentation: After an incubation period of 3–7 days, 
patients typically experience a sudden onset of fever, chills, 
headaches, body aches, weakness, vomiting, and nausea. Clinical 
plague infection manifests itself in three forms, depending on 
the route of infection: bubonic, septicaemic, and pneumonic. 
The bubonic form is the most common, resulting from the 
bite of an infected lea. The pneumonic form initially is directly 
transmitted from human to human via inhalation of infected 
respiratory droplets. 
Treatment: Rapid diagnosis and treatment are essential to 
reduce the risk of complications and death. Streptomycin, 
tetracyclines, and sulfonamides are the standard treatment. 
Gentamicin and luoroquinolones may represent alternatives 
when the above antibiotics are not available. Patients with 
pneumonic plague must be isolated to avoid respiratory 
transmission. 
Challenges ahead: Biological diagnosis of plague remains a 
challenge because most human cases appear in remote areas 
with scarce laboratory resources. So far, the main conirmation 
techniques were based on the isolation of Y. pestis (requiring a 
minimum of 4 days). The recent development of rapid diagnostic 
tests, now considered a conirmation method in endemic 
areas, opens new possibilities in terms of surveillance and case 
management.
Box 2. Recent International Meetings on Plague
• A meeting on plague in the present, past, and future was held 
by the Academy of Science and Letters, Oslo, Norway (http://
www.cees.no/oslo-plague-meeting). 
• A workshop focusing on the comparison of the Black Death and 
modern plague was organised by the Wellcome Trust Centre 
for the History of Medicine, University College, London (http://
www.ucl.ac.uk/histmed/).
• The World Health Organization convened an expert 
meeting in Antananarivo, Madagascar updating clinical 
plague deinitions, diagnostic methods, vaccines, and 
antimicrobial therapy, as well as reservoir and vector 
control strategies (http://www.who.int/csr/disease/plague/
interregionalmeeting2006/en/index.html).
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is striking, though, is our lack of understanding of this high-
profile disease in even the best-studied foci, particularly in 
Africa: often, we do not even know the natural reservoir of 
the bacilli. 
The capacity of the plague bacillus to form permanent 
foci under highly diverse ecological conditions attests to its 
extraordinary adaptability. During its emergence in Central 
Asia, Y. pestis accumulated copies of insertion sequences 
rendering its genome highly plastic [55]. The capacity to 
undergo genomic rearrangements may thus be an efficient 
means for the plague bacillus to adapt to new ecological 
niches. Yersinia pestis was, furthermore, recently shown to be 
able to acquire antibiotic resistance plasmids under natural 
conditions [56,57], probably during its transit in the flea 
midgut [58]. Of great concern is the recent observation of 
the presence of multidrug-resistant plasmids, almost identical 
to those acquired by Y. pestis, in a variety of enterobacteria 
isolated from retail meat products in the United States [59]. 
This bacterial reservoir of mobile resistance determinants 
is probably widespread globally and has the potential to 
disseminate to human and zoonotic bacterial pathogens, 
including Y. pestis. Obviously, the emergence and spread of 
multi-resistant strains of Y. pestis would represent a major 
threat to human health.
Finally, we should not overlook the fact that plague has 
been weaponised throughout history, from catapulting 
corpses over city walls, to dropping infected fleas from 
airplanes, to refined modern aerosol formulations [60,61]. 
The weaponisation research on plague carried out from 
before World War II until the 1990s fuelled a fear of 
biological warfare that may actually have stimulated research 
into surveillance and response strategies. More recently, 
however, fear of small-scale bioterrorism and the desire of 
governmental authorities to more fully control all access to 
plague materials risks stifling the research on plague ecology, 
epidemiology, and pathophysiology that is required to 
improve its clinical management in endemic areas. Terrorist 
use of an aerosol released in a confined space could result 
in significant mortality and widespread panic [60,61], and 
no one would wish plague weaponisation knowledge and 
material to fall into terrorist hands. However, the need for 
scientifically sound studies on the dynamics of infection, 
transmission, outbreak management, and improved 
surveillance and monitoring systems has never been greater.
Plague may not match the so-called “big three” diseases 
(malaria, HIV/AIDS, tuberculosis; see for example [62]) 
in numbers of current cases, but it far exceeds them in 
pathogenicity and rapid spread under the right conditions. 
It is easy to forget plague in the 21st century, seeing it as a 
historical curiosity. But in our opinion, plague should not 
be relegated to the sidelines. It remains a poorly understood 
threat that we cannot afford to ignore. 
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